Create your own polished presentation in minutes. Just describe what you need.
Free to try, no credit card requiredDiscussion:
Background of Current Research
Limitations:
Questions?
Identification of Methyl-CPG-Binding Protein 2 (MeCP2)
Differing Mutations in mice models
MeCP2 is not a global regulator of transcription
Further Research to identify targets of MeCP2
The complex problem of the Rett Syndrome gene mutation
Our Question and Hypothesis
Can CRISPR/Cas9 be used successfully to repair the MeCP2 mutation in Rett syndrome-induced mice models?
Hypothesis: Through the use of CRISPR/Cas9 system, the repair of the gene MeCP2 will also lead to correct regulation of its targets, therefore preventing the development of Rett syndrome and all its phenotypic symptoms in mice.
Our Question: Can CRISPR/Cas9 be used successfully to repair the MeCP2 mutation in Rett syndrome-induced mice models?
Complexity of the roles of MeCP2
Implications for human therapeutics
Results showed a successful replacement of mutant MeCP2 with functional MeCP2- CRISPR/Cas9 was successful
Contributions to field of study
Our Rationale
Multiple mutations of MeCP2 can knock-out its function
Countless number of targets of MeCP2
By repairing mutations at MeCP2, regulation will be corrected
Test Question:
Future Directions
The Stages of Retts:
Based off of this experiment, what happens when the CRISPR/Cas9 method is applied to the MeCP2 gene?
a) The mice develop symptoms of Rett syndrome.
b) The mice develop normally and exhibit no Rett syndrome symptoms.
c) The mice have higher anxiety levels.
d) The mice are not able to recognize objects.
Stage 2:
Stage 1:
Stage 4:
Stage 3:
Introduction:
What is Rett's Syndrome?
Using CRISPR/Cas9 to Repair MeCP2
Using CRISPR/Cas9 to repair MeCP2
Transgenic Mice with Human Mutated MeCP2 Gene
What Causes Rett's?
Current Therapies:
Object Recognition
Open Field Test
Mechanisms Behind Retts:
1) observation of motility
2-4) 5 small objects placed in an open
field w/the mice
-habituation occurs during these
sessions
5) two of the 5 objects are re-arranged
So What is MeCP2?
Use of the CRISPR/Cas9 System as a Gene Therapy Mechanism for Rett’s Syndrome in a Mouse Model
Anxiety Testing
Anxiety Testing
Elevated Plus Maze (EPM)
Zero Maze
Takeaway Facts:
Why It's Important:
- Plus shaped maze with two enclosed arms
and two open arms
- Essentially, the mouse has an aversion towards
the open spaces
- Mouse placed on maze for 5 minutes and
observed for measures of anxiety
Measures of Anxiety:
% of time spent in open arms/entries to open arms
# of entries to each of the arms
- Maze to test measures of anxiety
- Based on same principles as EPM
(aversion to open spaces)
- mice were individually placed on maze and
videotaped for 5 min.
Measures of anxiety:
% time spent freezing
% time spent on open arms
# of transitions between open → closed arms
AMIRA
Behavioral Test
Results
Volumetric Measures
Anxiety Measures Test
Behavioral Test
Results
Object Recognition Test
References:
*Control mice (with Rett's) had increased anxiety levels*
*MeCP2 Repaired mice had decreased
anxiety levels*
(if inefficient get results
like control.)
Volume Results
*Mice with repaired MeCP2 gene showed improved ability in object recognition ability*
(inefficient, similar results to control).
The amount of time (s) spent in physical contact with the DO (2 objects that have been moved) and NDO (objects that remained constant) is measured in session 5 relative to the amounts of time spent in session 4 for males (A) and females (B).
Amygdala
Hippocampus
Calfa, G., Percy, A. K., & Pozzo-Miller, L. (2011). ON
EXPERIMENTAL MODELS OF RETT SYNDROME BASED ON Mecp2
DYSFUNCTION.Experimental Biology and Medicine (Maywood, N.J.), 236(1), 3–19. http://doi.org/10.1258/ebm.2010.010261
Chadwick, Lisa Helbling, and Paul A. Wade. "MeCP2 in Rett
Syndrome: Transcriptional Repressor or Chromatin Architectural Protein?" Current Opinion in Genetics & Development 17.2 (2007): 121-25. Web.
Chahrour, Maria, and Huda Y. Zoghbi. "The Story of Rett
Syndrome: From Clinic to Neurobiology." Neuron 56.3 (2007): 422-37. Web.
Mari, Francesca, et al. "Genetics and Mechanisms of Disease in
Rett Syndrome." Drug Discovery Today: Disease Mechanisms 2.4 (2005): 419-25. Web.
Neul, Jeffrey L., and Huda Y. Zoghbi. "Rett Syndrome: A
Prototypical Neurodevelopmental Disorder." The Neuroscientist Neuroscientist 10.2 (2004): 118-28. Web.
"Quick Learning of CRISPR/Cas9." OriGene Technologies Inc., 7
May 2014. Youtube. Web. 23 Nov. 2015.
Who Did What:
References:
Intro- Meghan
Background -Delanie
Methods - Vivianne, Ghazal, Delanie
Results- Vivianne, Ghazal
Discussion - Delanie, Meghan
Ricceri L, De Filippis B, Laviola G. 2008
Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol. ;19(5–6):501–517.
Squire, L.R., Tecott, L.H., & Nestler, E.J.
2009. Encyclopedia of Neuroscience.
Tao J, Wu H, Sun YE. Deciphering Rett
syndrome with mouse genetics, epigenomics, and human neurons. Int Rev Neurobiol. 2009:89147–89160.
Stearns, N.A, Schaevitz,L.R., Bowling, H.,
Nag, N., Berger, U.B., Berger-Sweeney, J. 2007. Behavioral and anatomical abnormalities in Mecp2 mutant mice: A model for Rett syndrome. Neuroscience, 146 (3), 907-921.
Create your own polished presentation in minutes. Just describe what you need.
Free to try, no credit card required